In last trading session, Structure Therapeutics Inc ADR (NASDAQ:GPCR) saw 1.57 million shares changing hands with its beta currently measuring -1.67. Company’s recent per share price level of $21.42 trading at $0.89 or 4.34% at ring of the bell on the day assigns it a market valuation of $1.23B. That closing price of GPCR’s stock is at a discount of -192.9% from its 52-week high price of $62.74 and is indicating a premium of 9.48% from its 52-week low price of $19.39. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.07 million shares which gives us an average trading volume of 858.76K if we extend that period to 3-months.
For Structure Therapeutics Inc ADR (GPCR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Structure Therapeutics Inc ADR (NASDAQ:GPCR) trade information
Upright in the green during last session for gaining 4.34%, in the last five days GPCR remained trading in the red while hitting it’s week-highest on Thursday, 03/06/25 when the stock touched $21.42 price level, adding 9.12% to its value on the day. Structure Therapeutics Inc ADR’s shares saw a change of -21.02% in year-to-date performance and have moved -5.10% in past 5-day. Structure Therapeutics Inc ADR (NASDAQ:GPCR) showed a performance of -11.82% in past 30-days. Number of shares sold short was 6.92 million shares which calculate 8.29 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 118 to the stock, which implies a rise of 81.85% to its current value. Analysts have been projecting 118 as a low price target for the stock while placing it at a high target of 118. It follows that stock’s current price would drop -450.89% in reaching the projected high whereas dropping to the targeted low would mean a loss of -450.89% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -51.75% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 6.55% while estimates for its earnings growth in next 5 years are of -25.24%.
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s Major holders
Insiders are in possession of 4.83% of company’s total shares while institution are holding 110.51 percent of that, with stock having share float percentage of 116.11%. Investors also watch the number of corporate investors in a company very closely, which is 110.51% institutions for Structure Therapeutics Inc ADR that are currently holding shares of the company. CAPITAL RESEARCH GLOBAL INVESTORS is the top institutional holder at GPCR for having 3.13 million shares of worth $122.97 million. And as of 2024-06-30, it was holding 0.7104 of the company’s outstanding shares.
The second largest institutional holder is DRIEHAUS CAPITAL MANAGEMENT LLC, which was holding about 2.58 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.5847 of outstanding shares, having a total worth of $101.2 million.
